Akoustis 4Q23 results and more ?3
08:53 13-Feb-24
Akoustis
has
reported
its fourth quarter results:
- a loss of 19 cents per share misses by
a penny
- from $7M of revenue, which is in line
I've been listening to the conference call while monitoring other
market developments. Management says inventory has normalized. The
most important development to me so far is that 3 of top 10
customers were from Asia, though two of the top three were from
there. I see this diversification as crucial. The company is also
still participating in CHIPS Act via memberships with one worth
several million dollars. Management also projects a $4.2+/-0.5M tax
credit from the act, to be realized over the next 12-15 months.
Finally, management characterizes ongoing litigation between
Akoustis and Qorvo as proceeding favorably. This is a possible
reason for the short term only
funding,
along with progress toward break even operations. Even so, I'm not
prepared to re-enter an AKTS position above 50 cents.
We also saw a 30K
OMIB
at $1.5 on Friday from a Lumen Director
reported
last night. LUMN was up 20% to trade above $1.80 yesterday but is
deteriorating with the market ahead of CPI now. I view recent
optimism as unfounded, but could see the momentum in the stock
continuing for the short to medium term.
The just-released CPI
numbers
aren't helping, though, as they just came in one to two tenths
higher than expected in both the headline and core numbers. YoY
inflation was lower at 3.4%, though. Shelter continues to be the
main culprit, and I expect other commodities to eventually follow
suit.